400-000-0000

JIHUA GROUP

MEDICINE

HOME < JIHUA BUSINESS
RETURN

Drugs

Enterprise produces principally chemical agent-based integrated pharmaceutical productions. The main products are neurological and psychiatricagents, cerebrovascular & cardiovascular, agents, endocrine agents, antimicrobial and other agents. Enterprise have included...

READ MORE

MEDICINE

The enterprise currently has a mid-sized sophisticated modern pharmaceutical company with domestic first-class production process and pharmaceutical apparatus. It also owned a manufacturing company engaged in researching, developing, manufacturing and selling medical apparatus. Besides, the enterprise is also involved in the entire process of the design, development, production and service of “anesthesia machines, training injury comprehensive therapy apparatus, breast mass comprehensive therapy apparatus, and medical transfer bed”. It owns the international advanced testing centers, standardized quality assurance management system, strict internal control standards and a high level of knowledge professionals.
 

Directory

Product display

Drugs

  • Sertraline Hydrochloride Tablets®

  • Hydergine®

  • Diamicron®

Jihua Group

  • Dept. of International Cooperation

    The department is mainly responsible for Jihua Park project, JH1912 project, shoe soles project with Michelin, etc. Tel: +86-(0)10-65168926. Email: zhaot@jihuachina.com

  • Xinxing Jihua International Trading CO., LTD.

    It is one of the twelve military trade companies, which approved by the government and the army of China. Tel: +86-(0)10-63730966. Email:xxjhgj@163.com

Business development

Enterprise produces principally chemical agent-based integrated pharmaceutical productions. The main products are neurological and psychiatricagents, cerebrovascular & cardiovascular, agents, endocrine agents, antimicrobial and other agents. Enterprise have included simultaneously tablets, capsules, powder-injections,  large volume injection and other multiple forms of imported production lines, and have 128 Drug Approval numbers,, 14 new Drug certifications and various 40 patents. In 2013, tablets and capsules of enterprise had passed the national GMP certification of version 2010; in 2014, the powder-injection had passed the national GMP certification of version 2010.